CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ (162,572)	$ 6,209
Adjustments to reconcile net income / (loss) to net cash provided by (used in) operating activities
Depreciation and amortization	4,340	20,248
Interest expense on convertible debt	3,255	60,608
Loss on disposal of asset	7,500	0
Bad debt expense	0	9,558
Changes in assets and liabilities:
(Increase) decrease in accounts receivable	(147,790)	(239,598)
(Increase) decrease in inventory	119,354	97,683
(Increase) decrease in prepaid and other assets	(506,118)	(43,819)
Increase (decrease) in accrued royalties and expenses	53,449	(150,672)
Increase (decrease) in accounts payable	14,279	27,741
Increase (decrease) in accounts payable related parties	38,670	(54,115)
Increase (decrease) in accrued liabilities	139,490	65,711
Net cash flows provided by (used in) operating activities	(436,143)	(200,446)
Cash flows from investing activities:
Purchase of property and equipment	(6,794)	(1,297)
Cash received in reverse acquisition	508,973	0
Net cash flows from (used in) investing activities	502,179	(1,297)
Cash flows from financing activities:
Draw on line of credit	500,000	0
Net cash flows used in financing activities	500,000	0
Net increase (decrease) in cash	566,036	(201,743)
Cash and cash equivalents, beginning of period	176,421	463,189
Cash and cash equivalents, end of period	742,457	261,446
Cash paid during the period for:
Interest	2,170	0
Income Taxes	0	0
Supplemental non-cash investing and financing activities:
Common stock issued for dividends on Series C Preferred Stock	0	15,007
Common stock issued for conversion of Series C Preferred Stock	0	85,561
Common stock issued for conversion of Related Party debt and interest	0	1,585,594
Common stock issued in reverse capitalization; less cash received of $508,973	$ 1,666,537	$ 0